Pharmaceutical News

RSS

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Vioxx user was a heart attack waiting to happen

In the on-going court battle facing drug company Merck over it's blockbuster painkiller Vioxx, a lawyer for Merck has said one of the plaintiffs was more or less a heart attack waiting to happen regardless of Vioxx.

12 Jul 2006

Cardinal Health to manufacture Tamiflu for Roche

Cardinal Health, the leading provider of products and services supporting the health-care industry, has announced that it has signed agreements to manufacture and package Tamiflu for Roche to help meet current and future demand for the influenza medicine.

10 Jul 2006

New Australian 'assassin' drug has huge potential

Australian researchers have come up with a new drug which they believe has the potential to fight a wide range of illnesses and diseases including cancer, age-related blindness, heart disease and arthritis.

5 Jul 2006

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

Scientists have found that a new anti-smoking drug may be more effective than drugs currently in use to help smokers kick the habit and it has the added advantage of promoting longer-lasting abstinence.

5 Jul 2006

New drug restores sight in sufferers from AMD

A new drug with the capacity to reverse vision loss in some patients with age-related macular degeneration (AMD) has won approval from the Food and Drug Administration (FDA) in the U.S.

3 Jul 2006

3-drug pill will help fight HIV/AIDS

The Food and Drug Administration (FDA) in the U.S. has granted approval for a three-ingredient fixed dose tablet for use as an antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults.

3 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

Brits first to get new obesity drug

The drug Acomplia is a new weight loss preparation that curbs the desire to over-eat and British patients will be the first worldwide to access the medication.

28 Jun 2006

First-in-class biologics poised to drive malignant melanoma drug market

Decision Resources, Inc., a research and advisory firm focusing on pharmaceutical and healthcare issues, finds that first-in-class targeted biologics will enter the malignant melanoma market during the next five years.

27 Jun 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

FDA approves Exelon to treat dementia of Parkinson's disease

FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.

27 Jun 2006

Affymax and Takeda announce agreement for commercialization of Hematide for anemia

Affymax and Takeda Pharmaceutical Company have announced that the companies have entered into an exclusive global agreement to develop and commercialize Affymax's lead product candidate, Hematide, for the treatment of anemia.

27 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

Experimental drug helps you age gracefully

Researchers in the U.S. say they believe an experimental drug designed to kick-start growth hormones in humans may also be of advantage in the aging process.

22 Jun 2006

FDA warns of possible risks to children using Triaminic Vapor Patch

The U.S. Food and Drug Administration (FDA) today is warning consumers not to use the Triaminic Vapor Patch marketed by Novartis Consumer Health due to reports of serious adverse events associated with accidental ingestion by children.

19 Jun 2006

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

Doctors put their foot down over drug advertising

The American Medical Association (AMA), the largest doctors group in the U.S., has announced a new policy on the direct-to-consumer advertising of prescription drugs and implantable medical devices.

18 Jun 2006